Today's leading scientists used Adaptive's breakthrough technologies
to analyze the adaptive immune system in greater detail and depth than ever thought possible.
Dr. Cassian Yee
The University of Texas
MD Anderson Cancer Center
Dr. Kalos and his colleagues recently published two groundbreaking papers on a potential cure for leukemia. In the papers, they praised Adaptive's team and its immunoSEQ technology.
SEQing the impossible.
Dr. Michael Kalos,
University of Pennsylvania Medical School
"We discovered a way to take a measurement of the immune system that's significantly higher than all the other standards in the field."
Measure the impossible.
Dr. Harlan Robins,
Co-Founder, Adaptive Biotechnologies
